The Complete Guide to FDA-Compliant Packaging & Fulfillment
If you sell dietary supplements, OTC drug products, cosmetics, or regulated food items, your packaging and fulfillment operation isn't just a logistics function — it's a compliance function. The Food and Drug Administration has specific, enforceable requirements that govern how these products are manufactured, labeled, stored, handled, and shipped. Choosing a 3PL or contract packager that doesn't understand those requirements isn't just an operational risk. It's a regulatory liability.
Most brands in the health, beauty, and supplement space spend significant time and money getting their formulations and labels right. Then they hand the product off to a warehouse or co-packer that doesn't ask a single question about lot tracking, temperature control, or segregation protocols. That's where warning letters, import alerts, and FDA 483 observations start.
This guide covers what FDA compliance actually requires of packaging and fulfillment operations, the specific regulations that govern your product category, the questions you should be asking every 3PL you evaluate, and the common mistakes brands make when they assume their fulfillment partner "handles all of that."
FDA Regulatory Framework: Which Rules Apply to You
The FDA doesn't issue one blanket regulation for health and personal care products. Different product categories fall under different parts of the Code of Federal Regulations (CFR). Understanding which rules apply to your products is the first step to ensuring your 3PL can actually meet them.
Dietary Supplements: 21 CFR Part 111
Dietary supplements — vitamins, minerals, botanicals, amino acids, enzymes, and similar products — are governed by 21 CFR Part 111, the Current Good Manufacturing Practice (cGMP) regulations for dietary supplements. These rules apply to anyone who manufactures, packages, labels, or holds dietary supplements, which means your 3PL is directly covered if they touch your product.
Under Part 111, your packaging and fulfillment facility must maintain written procedures for receiving components and finished products, conduct identity testing or obtain certificates of analysis, maintain batch and lot records, control packaging and labeling operations to prevent mix-ups, and ensure that physical plant and equipment meet sanitation and maintenance standards.
The "holds" coverage is particularly important. A fulfillment center that stores your supplements and ships them to consumers is considered to be "holding" a dietary supplement under 21 CFR 111.3. That facility must comply with applicable subparts of Part 111 — not just your manufacturer.
Food Products: 21 CFR Parts 110 and 117
Food products, including certain functional foods and beverages, are governed by 21 CFR Part 110 (the older cGMP standard) and more recently 21 CFR Part 117, which implements the Food Safety Modernization Act (FSMA) preventive controls framework. Part 117 requires a written food safety plan, hazard analysis, preventive controls, monitoring procedures, and corrective action protocols.
For fulfillment operations handling food products, this means demonstrating that the facility can identify and control biological, chemical, and physical hazards — including those that can be introduced during packaging, storage, and shipping.
OTC Drug Products: 21 CFR Parts 210 and 211
Over-the-counter drug products face the most stringent requirements. Parts 210 and 211 establish cGMP for finished pharmaceuticals, covering everything from building and facility standards to laboratory controls, batch record requirements, and product release processes. If you manufacture or co-pack OTC products — sunscreen, acne treatments, antifungals, and a large range of other categories — your packaging partner must meet these standards.
Cosmetics: FD&C Act and Modernization of Cosmetics Regulation Act (MoCRA)
The Modernization of Cosmetics Regulation Act of 2022 significantly expanded FDA's authority over cosmetics for the first time in decades. As of late 2024, cosmetic facilities that manufacture or process cosmetics for sale in the U.S. must register with the FDA and submit product listings. Facilities must also comply with forthcoming cGMP regulations specifically for cosmetics, maintain records, and report serious adverse events.
For cosmetic brands, this means your co-packer or 3PL may now be considered a "responsible person" with its own FDA obligations, depending on what services they perform.
cGMP Requirements for Packaging Facilities
Current Good Manufacturing Practice is not a single checklist — it's a philosophy of quality systems, written procedures, and documented evidence. When evaluating a packaging or fulfillment facility for FDA-regulated products, cGMP compliance breaks down into several operational areas.
Physical Plant and Equipment
21 CFR Part 111 and Part 211 both require that facilities be of suitable size, construction, and design to facilitate cleaning, maintenance, and proper operations. This includes adequate lighting, ventilation, and sanitary design. Equipment used in manufacturing or packaging operations must be of appropriate design and construction, maintained in a clean and orderly condition, and qualified and calibrated on a documented schedule.
For a 3PL that handles supplements or OTC products, this means documented cleaning protocols between product runs, sanitation logs, preventive maintenance records, and equipment qualification documentation that can be produced during an FDA inspection or a client audit.
Segregation and Contamination Prevention
One of the most common compliance failures in warehouse and co-pack environments is inadequate physical segregation. Products under quality hold must be physically separated from released product. Different allergen profiles, different product categories, and different customers' products must be stored in a manner that prevents cross-contact and mix-ups.
Regulatory language under 21 CFR 111.15(b) requires that operations be conducted "with adequate lighting, ventilation, and screening or other protection against pests" and that "operations be conducted in a manner that prevents contamination." In practical terms, this means dedicated storage areas, clearly marked hold zones, and written procedures for what happens when a product fails incoming inspection.
Personnel Qualifications and Training
cGMP regulations require that all personnel engaged in manufacturing, packaging, labeling, or holding operations have the education, training, and experience to perform their assigned functions. 21 CFR 111.13 requires that training be documented. This is often overlooked in traditional warehousing environments, where turnover is high and training documentation is inconsistent.
A compliant 3PL maintains training records for all employees who handle your product, covers topics including GMP fundamentals, sanitation, allergen awareness, label verification procedures, and any product-specific requirements you've communicated.
FDA Labeling Compliance: What Gets Caught and What Gets Missed
Label compliance is where many brands and their fulfillment partners create unintended regulatory violations. The FDA's labeling requirements are product-category specific, but several principles apply broadly.
Identity, Net Quantity, Ingredient Declarations, and Claims
For dietary supplements, 21 CFR Part 101 and the Dietary Supplement Health and Education Act (DSHEA) govern label content. Required elements include the statement of identity (e.g., "Dietary Supplement"), net quantity of contents, Supplement Facts panel, list of ingredients in descending order by weight, name and place of business of the manufacturer or distributor, and directions for use. Any structure/function claims must include the FDA disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
For OTC drugs, labeling requirements under 21 CFR Part 201 and the OTC monograph system are even more prescriptive. Drug Facts panels must follow specific format requirements including font size, heading order, and placement on the principal display panel or outer carton.
Lot Number and Expiration Date Requirements
21 CFR 111.415 requires that every finished batch of dietary supplement be identified with a lot or batch number that enables full traceability back to the production or packaging event. That lot number must appear on the label or be otherwise associated with each unit in a way that allows recall or investigation if a quality issue is identified.
For OTC drugs, lot number and expiration dating requirements are equally stringent under Parts 211.130 and 211.137. The expiration date must be clearly labeled on the immediate container and, where applicable, on the outer packaging.
This has direct operational implications for your 3PL. If your fulfillment partner doesn't have the systems to scan, record, and track lot numbers at both inbound receiving and outbound shipment, you have a compliance gap. First-expired, first-out (FEFO) inventory management isn't optional for regulated products — it's a core GMP requirement.
Version Control and Label Obsolescence
In co-pack and kitting environments, an often-overlooked compliance risk is obsolete label stock. FDA inspections have uncovered situations where products were packaged using an old label version because the 3PL warehouse still had old stock on the shelf after a label update. Written procedures for label reconciliation, label destruction for obsolete versions, and label issuance control are required under 21 CFR 111.415 and Part 211.
Lot Tracking and Traceability
For regulated products, traceability isn't just a nice-to-have for customer service inquiries. It is the operational foundation of an effective recall, the evidence basis for a regulatory response, and a legal requirement.
What Full Traceability Requires
A compliant lot tracking system must be able to answer two questions in both directions: "Where did this lot go?" (forward trace) and "What came in that was used to make or package this lot?" (backward trace). For finished goods fulfillment, forward traceability means being able to identify every order, every customer, and every shipment that contained a specific lot number. That capability is required to conduct a targeted recall rather than a blanket market withdrawal.
Under 21 CFR 111.260 through 111.265, batch production records for dietary supplements must include the lot or batch number, the identity and weight of each component used, in-process monitoring results, any deviations and their investigation, and the disposition of the batch. Even if your 3PL is only performing packaging and labeling (not manufacturing), they must maintain records linking the components they received to the finished goods they shipped.
System Requirements for 3PL Lot Tracking
Ask your 3PL specifically how lot numbers are captured. Are they scanned at receiving and linked to your inventory system? Are they recorded at the pallet, case, and unit level? Are they captured on outbound shipments and linked to individual orders? Can they generate a lot-specific shipment report within hours — not days — if you initiate a recall?
The FDA's response to the 2023 and 2024 infant formula and supplement adulteration events has accelerated agency interest in supply chain traceability. The FSMA Section 204 Food Traceability Rule, which applies to certain high-risk food categories and carries full compliance requirements as of January 2026, requires maintaining Key Data Elements at each Critical Tracking Event. While not all supplement brands fall under Section 204, the direction of regulatory expectation is clear.
Temperature, Storage, and Handling Requirements
Storage conditions are not an afterthought for regulated products. They are a compliance requirement with direct product quality implications.
Defined Storage Conditions
Many dietary supplements and OTC products have labeled storage conditions: "Store below 77°F," "Keep in a cool, dry place," or "Store in a refrigerator." Under 21 CFR Part 111 and Part 211, the facility holding your product is responsible for ensuring that storage conditions conform to those specifications. That requires temperature-monitored storage areas, calibrated monitoring equipment, alarm systems for excursions, and documented response procedures.
If your product requires refrigeration, your 3PL must have cGMP-compliant cold chain capability — not just a refrigerator in the corner. That means qualified cold storage zones, continuous temperature monitoring with data logging, excursion investigation procedures, and the ability to demonstrate temperature compliance for any given product lot during any given time period.
Humidity and Environmental Controls
Some products — particularly certain botanical supplements, powders, and hygroscopic ingredients — are sensitive to humidity as well as temperature. Moisture can drive microbial growth, degrade active ingredients, or compromise packaging integrity. A compliant facility monitors and controls relative humidity in storage and production areas and maintains those records.
Pest Control
Both 21 CFR Part 110 and Part 111 require effective pest control programs. In a warehouse environment, this means documented integrated pest management contracts, regular inspections, logs of pest activity and treatments, and procedures for handling product that has been exposed to pest activity.
Common Compliance Mistakes Brands Make
Understanding what goes wrong in practice is as useful as understanding what the regulations require.
Assuming the manufacturer's cGMP covers the 3PL. Your manufacturer may be fully cGMP compliant, but once your product leaves their dock and arrives at a fulfillment center, the regulatory obligations don't stop. The facility holding and shipping your product carries its own responsibilities. Many brands have discovered this only after an FDA inspection of their fulfillment partner.
Not auditing the 3PL before the contract. Supplier qualification under cGMP frameworks (including 21 CFR 111 for supplements and Part 211 for OTCs) requires that you evaluate and qualify your contract service providers. Signing a fulfillment agreement based solely on price and SLA without a facility audit and quality agreement is a compliance vulnerability.
Missing the quality agreement. A quality agreement between brand and 3PL defines the division of cGMP responsibilities in writing. Without one, it's ambiguous who is responsible for label verification, lot tracking, temperature monitoring, and documentation. Quality agreements are an FDA expectation, not just a best practice.
Label mix-ups in kitting and assembly. Multi-SKU kit operations are a frequent source of label errors. If your 3PL is assembling subscription boxes, gift sets, or bundled products that include your regulated items, the label verification and reconciliation procedures for those operations must be just as rigorous as for single-SKU shipments.
No procedure for damaged or returned product. What happens when a customer returns a supplement? When a pallet is damaged in transit? When a shipment arrives with visible temperature excursion evidence? A compliant operation has written procedures for each of these situations — including whether damaged or returned product can be restocked, held for investigation, or must be destroyed.
Expiration date management. FEFO is the rule for regulated products, but many general-purpose 3PLs default to FIFO without the systems to differentiate lots by expiration date. If your product has a 24-month shelf life, this is manageable. If it's 12 months or less — common for probiotic supplements, certain OTC formulations, and fresh beauty products — expiration date management becomes a daily operational priority.
What to Ask Your 3PL About Compliance
Before signing a fulfillment or co-pack agreement for regulated products, work through these questions directly with the facility's quality or operations team.
Regulatory history. Have you ever received an FDA warning letter, been placed on import alert, or had a facility inspection that resulted in a Form 483 observation? If so, what was the issue and how was it corrected?
cGMP experience. Do you have experience with 21 CFR Part 111 (dietary supplements), Part 211 (OTC drugs), or Part 117 (food preventive controls)? Have your operations been audited to these standards by clients or third parties?
Lot tracking capability. How do you capture lot numbers at receiving? Can you generate a lot-specific shipment report for a product recall? What's your system, and who is responsible for lot record maintenance?
Label control. What is your procedure for receiving, storing, issuing, and reconciling labels? How do you ensure obsolete labels are removed from circulation when a new version is approved?
Temperature monitoring. How are your storage areas monitored? What equipment do you use, how often is it calibrated, and what happens when a temperature excursion occurs?
Quality agreement. Are you willing to execute a quality agreement that defines each party's cGMP responsibilities in writing?
Facility audit. Can we conduct an on-site facility audit before signing a contract, and annually thereafter?
A 3PL that deflects these questions or is unfamiliar with the concepts behind them is not a suitable partner for regulated products, regardless of price.
How AnkerPak Supports FDA-Regulated Brands
AnkerPak operates 350,000 square feet of warehouse and production space across four facilities in Columbus, Georgia. Our operations serve brands in the health, beauty, and supplement space that need a co-packer and fulfillment partner who understands the regulatory environment — not just the logistics.
Our quality systems are designed around cGMP principles. We maintain documented receiving procedures with lot capture at intake, temperature-monitored storage zones with continuous data logging, trained personnel with documented qualification records, and formal label control procedures that include version management and reconciliation. We execute quality agreements with regulated-product clients as a standard part of onboarding — because defining responsibilities in writing protects both parties.
For brands navigating FDA compliance while trying to scale, Columbus, Georgia offers a strategic advantage beyond our facility capabilities. Our proximity to the Port of Savannah — the second-largest container port on the East Coast — means inbound raw material shipments and outbound finished goods both move efficiently through a world-class logistics corridor. If you're reshoring production, consolidating vendors, or building out a domestic supply chain that can respond to regulatory changes without depending on overseas flexibility, this geography matters.
We work with Fortune 500 clients and emerging brands across 11 production lines built for the kinds of specialized packaging operations that regulated products require: clean production environments, documented changeover procedures, kitting and assembly with label verification steps built into the workflow.
If you're evaluating 3PL or contract packaging partners for dietary supplements, OTC products, cosmetics, or regulated food items and want to understand specifically how our operations would support your compliance requirements, reach out to our team. We're comfortable answering the hard questions — and if we don't meet your requirements, we'll tell you that too.
Regulatory requirements evolve. This guide reflects FDA rules and guidance current as of early 2026. Brands should consult with a regulatory affairs professional for product-specific compliance advice.